Recruiting Ulcerative Colitis Studies in Liberty
Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis
This is a randomized, double-blind, placebo controlled, dose-ranging Phase 2 study. The primary objective is to evaluate the efficacy and safety of SAR443122 compared to placebo in participants with m...
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
This is a Phase 2, multicenter, platform study in adult participants with IBD (moderately to severely active Crohn's Disease or Ulcerative Colitis). The primary goal of this study is to assess the saf...
About Ulcerative Colitis Clinical Trials in Liberty
Ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the innermost lining of the colon and rectum. It typically presents with bloody diarrhea, abdominal pain, and urgency. Treatment includes aminosalicylates, corticosteroids, immunosuppressants, and biologics.
There are currently 2 ulcerative colitis clinical trials recruiting participants in Liberty, MISSOURI. These studies are seeking a combined 272 participants. Research is being sponsored by Sanofi, Mirador Therapeutics, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Ulcerative Colitis Clinical Trials in Liberty — FAQ
Are there ulcerative colitis clinical trials in Liberty?
Yes, there are 2 ulcerative colitis clinical trials currently recruiting in Liberty, MISSOURI. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Liberty?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Liberty research site will contact you about next steps.
Are clinical trials in Liberty free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Liberty studies also compensate for your time and travel.
What ulcerative colitis treatments are being tested?
The 2 active trials in Liberty are testing new therapies including novel drugs, biologics, and treatment approaches for ulcerative colitis.
Data updated March 2, 2026 from ClinicalTrials.gov